Presentation TCT 2012 What is the Potential Economic Impact of Antiproliferative Technologies in the SFA? Presenter: Mark Burket October 22, 2012
Presentation TCT 2012 Screening Patients for Clinical Trial Eligibility: The Painful but Essential Step Presenter: David Cox October 22, 2012
Presentation TCT 2012 Case 4: A Retrograde Failure That Changed My Clinical Practice Presenter: Georgios Sianos October 22, 2012
Presentation TCT 2012 The Clinical Epidemiology of Venous Thrombosis and Thromboembolism: A Primer for the Interventionalist Presenter: Raghotham Patlola October 22, 2012
Presentation TCT 2012 An Introduction to Cost-Effectiveness Analyses: Who Pays (and Should They)? Presenter: David Cohen October 22, 2012
Presentation TCT 2012 Composite Endpoints in Clinical Trials: Why Do We Need Them and How Do You Interpret Them? Presenter: Giuseppe Biondi Zoccai October 22, 2012
Presentation TCT 2012 Selecting the Patient Most Likely to Benefit from Renal Intervention Presenter: Massoud Leesar October 22, 2012